Evidence map›Paper›PMID 42180537›Full record

ReviewActa pharmaceutica Sinica. B2026

Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.

Ana Lizeth Padilla, José L Lanciego, Miquel Vila, Fernando de Castro, David Pozo, Fernando Rodríguez de Fonseca, Antonia Serrano, Javier Sáez-Valero, Lucía Núñez, Carlos Villalobos and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana Lizeth PadillaExcellence Unit Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), University of Valladolid & Consejo Superior de Investigaciones Científicas (CSIC), Valladolid 47003, Spain.
José L LanciegoCNS Gene Therapy Program, Center for Applied Medical Research (CIMA) University of Navarra, Pamplona 31008, Spain.
Miquel VilaCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid 28029, Spain.
Fernando de CastroInstituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid 28002, Spain.
David PozoAndalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), Málaga 29001, Spain.
Fernando Rodríguez de FonsecaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), Málaga 29590, Spain.
Antonia SerranoInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), Málaga 29590, Spain.
Javier Sáez-ValeroCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid 28029, Spain.
Lucía NúñezExcellence Unit Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), University of Valladolid & Consejo Superior de Investigaciones Científicas (CSIC), Valladolid 47003, Spain.
Carlos VillalobosExcellence Unit Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), University of Valladolid & Consejo Superior de Investigaciones Científicas (CSIC), Valladolid 47003, Spain.
Victor TapiasExcellence Unit Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), University of Valladolid & Consejo Superior de Investigaciones Científicas (CSIC), Valladolid 47003, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic (DA) neurons and the pathological aggregation of

Indexed as

Cell-based therapyDopamine neuronsMitochondrial dysfunctionNeuroprotectionParkinson's diseaseRegenerationStem cellsTransplantation

Identifiers

PMID42180537
PMCPMC13198280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.